Pay in 4 interest-free payments of $5.52 Learn more
Ships within 48 hours · Estimated delivery Aug 24 - Aug 29
Last month, the Delhi High Court restrained the company from launching its oral brand Olymviq, citing its phonetic similarity to the innovator's (Novo Nordisk) trademark Ozempic. Dr Reddys has submitted to market the product under the revised name Olymra. Notably, while Novo Nordisks holds market exclusivity on the oral pill Rybelsus until 2031, generic competitors have advanced non-infringing formulations that fall outside the scope of its patent protection
Main effects The main finding from this trial was that participants randomized to tirzepatide, lost more weight on average, compared to those randomized to semaglutide
2.5 mg/mL concentration This is one of the most popular concentrations, especially from pharmacies that add B12 (cyanocobalamin) to the formulation
Facile synthesis of a biocompatible silver nanoparticle derived tripeptide supramolecular hydrogel for antibacterial wound dressings
